Our work

Looking for the best constrained peptide binders for your target protein of interest?

Our peptide discovery experts apply Pepscan’s proprietary peptide technologies, peptide chemistry expertise and our strong track record in contract research and R&D collaborations in our comprehensive peptide drug discovery service. Pepscan’s business model for peptide discovery projects is fee-for-service, including several options for success-based fees.

We provide the complete CLIPSTM peptide discovery pipeline under one roof in our facility in the Netherlands. Our services include hit validation, binding-site identification and lead optimization on proprietary peptide arrays, as well as R&D and clinical peptide synthesis. Our highly trained staff has years of experience in peptide display, synthesis, design, optimization and the molecular recognition of peptides, and will guide and support you in your peptide discovery journey.

The companies we’ve been working for

Our team has worked for amongst others: Novartis, Leo Pharma , Abreos Biosciences and Viewpoint on their peptide discovery projects.

Case: Abreos - Discovery of CLIPS-binders to anti-TNFa mAb’s using Phage Display Libraries

We use cookies to ensure that we give you the best experience on our website. We also use cookies to ensure we show you advertising that is relevant to you. If you continue without changing your settings, we’ll assume that you are happy to receive all cookies on the Pepscan website. However, if you would like to, you can change your cookie settings at any time in your browser.
Cookie Policy
Find out more
Accept All Cookies
By continuing to browse or by clicking "Accept All Cookies" you agree to the storing of first and third-party cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
Cookie Policy
Cookie Settings
Accept All Cookies